T0	Outcomes 626 648	periods of neutropenia
T1	Outcomes 769 819	shorter periods of platelet-transfusion dependency
T2	Outcomes 886 910	shorter hospitalizations
T3	Outcomes 1012 1125	frequency and severity of toxicities, development of pneumonia or infection, in-hospital death, and response rate
T4	Outcomes 1168 1199	long-term disease-free survival
T5	Outcomes 1358 1413	lower total charges after infusion of autologous marrow
T6	Outcomes 1519 1546	lower post-infusion charges
T7	Outcomes 1705 1750	acceleration of myeloid and platelet recovery
T8	Outcomes 1759 1773	cost effective